Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

High-Throughput Nucleotide Sequencing × CNS × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Gynecologic 1 CNS 1 Breast 1

Conditions

Neuroblastoma 1 Neoplasms 1

Interventions

Temozolomide 74 Magnetic Resonance Spectroscopy 65 Specimen Handling 44 Radiotherapy 42 Radiosurgery 28 Cyclophosphamide 27 Radiation 22 pembrolizumab 21 Biopsy 19 Bevacizumab 16 Nivolumab 15 Carboplatin 14 Irinotecan 13 Etoposide 13 Vincristine 11 fludarabine 10 dinutuximab 10 Ipilimumab 10 abemaciclib 9 AZD 6244 9 X-Rays 8 Lomustine 8 trametinib 7 niraparib 7 Topotecan 7 Surgical Procedures, Operative 7 Granulocyte-Macrophage Colony-Stimulating Factor 7 Eflornithine 7 Cisplatin 7 Blood Specimen Collection 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡